LOSS OF EPIDERMAL GROWTH-FACTOR REQUIREMENT AND MALIGNANT TRANSFORMATION

被引:124
|
作者
CHERINGTON, PV
SMITH, BL
PARDEE, AB
机构
[1] SIDNEY FARBER CANC INST, TUMOR BIOL LAB, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DEPT PHARMACOL, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT MICROBIOL & MOLEC GENET, BOSTON, MA 02115 USA
关键词
D O I
10.1073/pnas.76.8.3937
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Serum provides growth factors that regulate and limit the growth of normal cells in tissue culture. Animal cells that are malignantly transformed usually exhibit diminished serum requirements for growth in culture. A defined, serum-free medium was used to determine which of these growth factors becomes dispensable for the growth of transformed Syrian and Chinese hamster fibroblast cells. The medium''s 4 growth factors (epidermal growth factor (EGF), insulin, fibroblast growth factor and transferrin) were added or omitted as desired. A decreased requirement for EGF was most closely related to tumorigenicity of chemically (ethyl methanesulfonate) transformed cells in nude mice. All lines examined retained their requirement for transferrin, which is needed throughout the growth cycle, in contrast to the other factors, which are needed primarily in G1 phase. Lines that had lost their EGF requirement but had retained their insulin requirement were arrested in G1 by insulin deficiency, indicating that their growth control system remained. Mutagenesis with ethyl methanesulfonate can also create requirements of the transformed cells for unknown factors in serum. An initial step that reduces the serum requirement in culture and in tumorigenesis is apparently relaxation of the growth-regulatory function of EGF.
引用
收藏
页码:3937 / 3941
页数:5
相关论文
共 50 条
  • [22] IMMUNOHISTOCHEMICAL STUDY OF EPIDERMAL GROWTH-FACTOR IN BENIGN AND MALIGNANT GENITOURINARY TISSUES
    LAU, JL
    FOWLER, JE
    GHOSH, L
    JOURNAL OF UROLOGY, 1987, 137 (04): : A110 - A110
  • [23] INTERACTIONS OF MALIGNANT AND NORMAL HUMAN UROTHELIAL CELLS WITH EPIDERMAL GROWTH-FACTOR
    MESSING, E
    REZNIKOFF, C
    JOURNAL OF UROLOGY, 1987, 137 (04): : A111 - A111
  • [24] EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH FACTOR-ALPHA BIND DIFFERENTLY TO THE EPIDERMAL GROWTH-FACTOR RECEPTOR
    WINKLER, ME
    OCONNOR, L
    WINGET, M
    FENDLY, B
    BIOCHEMISTRY, 1989, 28 (15) : 6373 - 6378
  • [25] EPIDERMAL GROWTH-FACTOR AND INTESTINAL GROWTH
    GOODLAD, RA
    PLAYFORD, RJ
    GASTROENTEROLOGY, 1995, 108 (04) : 1330 - 1331
  • [26] STABILIZATION OF EPIDERMAL GROWTH-FACTOR
    NJIEHA, FK
    SHALABY, SW
    JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 1992, 7 (03) : 288 - 299
  • [27] SECRETION OF EPIDERMAL GROWTH-FACTOR
    ROBERTS, ML
    JOURNAL OF DENTAL RESEARCH, 1977, 56 : A88 - A88
  • [28] EPIDERMAL GROWTH-FACTOR IN THE ESOPHAGUS
    JANKOWSKI, J
    COGHILL, G
    TREGASKIS, B
    HOPWOOD, D
    WORMSLEY, KG
    GUT, 1992, 33 (11) : 1448 - 1453
  • [29] EPIDERMAL GROWTH-FACTOR DEPENDENT TRANSFORMATION BY A HUMAN EGF RECEPTOR PROTOONCOGENE
    VELU, TJ
    BEGUINOT, L
    VASS, WC
    WILLINGHAM, MC
    MERLINO, GT
    PASTAN, I
    LOWY, DR
    SCIENCE, 1987, 238 (4832) : 1408 - 1410
  • [30] EPIDERMAL GROWTH-FACTOR AND THE KIDNEY
    FISHER, DA
    SALIDO, EC
    BARAJAS, L
    ANNUAL REVIEW OF PHYSIOLOGY, 1989, 51 : 67 - 80